Highest-materiality recent filing
Core Scientific subsidiary prices $3.3B of 7.750% senior secured notes due 2031
Issuer Core Scientific Finance I LLC priced $3.3B notes at 99.250% of par; net proceeds ~$3.24B.
Core Scientific to acquire Polaris DS for ~$421M; Muskogee campus expansion to 1.5 GW
Total purchase price ~$421M in cash; additional $40M if 40 MW of firm capacity available by Dec 31, 2026.
Core Scientific Q1 2026: Revenue up to $115.2M but net loss $347.2M; closes $3.3B notes
Revenue $115.2M (+45% YoY); colocation revenue $77.5M (vs $8.6M) driving growth.
Core Scientific plans to scale Pecos campus to 1.5 GW gross power
Plans to expand Pecos, TX campus to approx. 1.5 GW gross power / 1.0 GW leasable power.
Core Scientific proposes $3.3B senior secured notes due 2031 to repay bridge loans
Offering of $3.3B aggregate principal amount of senior secured notes due 2031 by subsidiary Core Scientific Finance I LLC.
Core Scientific increases credit facility to $1.0B with additional $500M from JPMorgan
Total commitments under facility now $1.0B, up from $500M previously from Morgan Stanley.
Core Scientific secures $500M Morgan Stanley loan facility, accordion to $1B
Initial $500M 364-day term loan facility with Morgan Stanley; interest SOFR + 2.50%.
Restatement for Non-Reliance Periods from June 30, 2024 through Sept 30, 2025 due to improper capitalization of assets committed to demolition during mining-to-HPC conversion.
Company agrees to appoint first new independent director by March 15, 2026, second by Sept 15, 2026, third before 2027 annual meeting.
Shareholders vote against CoreWeave merger; Core Scientific terminates deal
Merger proposal received 20.8M for vs 203.5M against, failing to pass.
Core Scientific stockholders fail to approve merger with CoreWeave
At special meeting on Oct 30, 2025, Core Scientific did not receive requisite votes to approve merger with CoreWeave (CRWV).
Core Scientific terminates merger with CoreWeave after shareholders reject deal
At Oct 30 special meeting, Core Scientific stockholders did not approve the merger agreement with CoreWeave.
Total revenue $81.1M, down 15% YoY from $95.4M; digital asset self-mining revenue $57.4M, bitcoin mined down 55%, avg BTC price up 88%.
Core Scientific proposes merger with CoreWeave in all-stock deal at 71% premium
Stockholders to receive 0.1235 CoreWeave shares per CORZ share — 71% premium to 10-day VWAP as of June 25, 2025.
Core Scientific investor presentation shows ~71% premium in CoreWeave merger; vote Oct 30
Exchange ratio of 0.1235 CoreWeave shares per CORZ share, a ~71% premium to unaffected 10-day VWAP.
Core Scientific Q2 revenue $78.6M, down 44% YoY; net loss $936.8M on warrant adjustments
Total revenue $78.6M, down from $141.1M YoY; digital asset self-mining revenue $62.4M (down 44%).
CoreWeave to acquire Core Scientific in ~$9B all-stock deal; 0.1235 CRWV shares per CORZ
Total equity value ~$9.0B based on fully diluted shares and CoreWeave 5-day VWAP as of July 3, 2025.
Core Scientific agrees to be acquired by CoreWeave in all-stock merger
Each CORZ share will convert into 0.1235 shares of CoreWeave Class A common stock; exchange ratio fixed.
Core Scientific say-on-pay fails; shareholders approve 48M share incentive plan
Say-on-pay vote fails with 113.6M against vs 70.4M for (61% opposed); non-binding but strong shareholder disapproval.
Core Scientific Q1 net income $580.7M on warrant adjustment; revenue down 56% to $79.5M
Net income $580.7M vs $210.7M YoY, driven by $621.5M non-cash mark-to-market on warrants due to stock price decline.
Core Scientific appoints Jim Nygaard as CFO effective March 17; Sterling departs May 1
Jim Nygaard named EVP, CFO effective March 17; 30 years of investment banking/M&A expertise from XMS Capital and Morgan Stanley.
Core Scientific expands CoreWeave deal by 70MW at Denton, TX; adds $1.2B in revenue
New 70MW expansion at Denton site brings total contracted HPC capacity with CoreWeave to ~590MW across six sites.
Core Scientific Q4 net loss $265.5M; revenue down 33% YoY to $94.9M
Net loss of $265.5M driven by $224.7M non-cash mark-to-market adjustment on warrant liabilities due to stock price increase.
On May 26, 2026, the Company announced the appointment of Steve M. Smith, as a member of the Board and the Nominating and Corporate Governance Committee of the Board, effective immediately.
On May 14, 2025, the Board appointed Elizabeth Crain as a member of the Board and the Chair of the Audit Committee of the Board, effective immediately.
On May 13, 2025, Todd Becker informed the Board of Directors (the “Board”) of Core Scientific, Inc. (the “Company”) of his resignation as a member of the Board and the applicable committees thereof, effective immediately.
On March 2, 2025, the Board of Directors (the “Board”) of Core Scientific, Inc. (the “Company”) approved the appointment of James P. Nygaard, Jr., age 50, as the Company’s Executive Vice President, Chief Financial Officer, effective March 17, 2025.
Max materiality 1.00 · Median 0.72 · Most common event other_material